According to Zhitong Finance App, Zaiding Pharmaceutical (09688) announced the private placement of a total of 11.34 million American Depositary Shares on October 27, 2026 (EST).

Leerink Partners LLC acts as the exclusive placement agent for private placements.

The Company intends to use the net proceeds from private placement mainly to support the continued global development of its Delta-like Ligand 3 (DLL3) antibody-conjugate drug (ADC) targeting Zocilurtatug Pelitecan (zoci).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.